Daily Issue → inbox:
TYBR Health raised a $30M Series A to expand its FDA-cleared B3 GEL System and fund clinical studies in orthopedic tissue protection.
expand its FDA-cleared B3 GEL System and fund clinical studies in orthopedic tissue protection.